Why the study?
Renal Ewing's sarcoma with inferior vena cava (IVC) tumour thrombus is a rare, aggressive malignancy that may mimic renal cell carcinoma (RCC) on imaging, creating diagnostic and therapeutic challenges.
Does a biopsy-first approach with neoadjuvant systemic chemotherapy improve surgical outcomes and reduce postoperative morbidity compared to upfront radical nephrectomy and IVC thrombectomy in young patients with primary renal Ewing's sarcoma and level II IVC tumour thrombus?
Case Report (n=2)
No
Does a biopsy-first approach with neoadjuvant systemic chemotherapy improve surgical outcomes and reduce postoperative morbidity compared to upfront radical nephrectomy and IVC thrombectomy in young patients with primary renal Ewing's sarcoma and level II IVC tumour thrombus?
In clinically stable patients with suspected primary renal Ewing's sarcoma and IVC tumour thrombus, early image-guided biopsy and neoadjuvant chemotherapy can achieve marked tumour and thrombus downsizing (73.9% reduction) and reduce perioperative morbidity compared to upfront radical surgery.
Answers are grounded in this paper and cite their sources.
May favor biopsy-first neoadjuvant chemotherapy to limit morbidity in renal Ewing's sarcoma with IVC thrombus; leaves open prospective confirmation before practice change.
Renal Ewing's sarcoma with inferior vena cava (IVC) tumour thrombus is a rare and aggressive malignancy that may mimic renal cell carcinoma (RCC) on imaging, creating diagnostic and therapeutic challenges. We report two young female patients presenting with large renal masses and level II IVC tumour thrombus who were managed using contrasting treatment sequences. In the first patient, image-guided biopsy established the diagnosis, allowing neoadjuvant systemic chemotherapy that resulted in substantial tumour and thrombus downsizing and facilitated subsequent surgical resection. In the second patient, persistent haematuria and progressive anaemia prompted urgent upfront surgery, which was followed by significant postoperative morbidity and delayed initiation of systemic chemotherapy. These contrasting cases highlight the potential value of early tissue diagnosis in selected clinically stable patients with atypical renal masses and emphasise that treatment sequencing should be individualised according to clinical status, tumour extent, thrombus burden, and multidisciplinary assessment.
No takes yet. Share an insight, caveat, or question.
Navriya et al. (2026) conducted a case report in Renal Ewing's sarcoma with level II inferior vena cava (IVC) tumour thrombus (n=2). Biopsy-first approach with neoadjuvant chemotherapy (VAC/IE followed by VIT) prior to radical nephrectomy and IVC thrombectomy vs. Upfront radical nephrectomy and IVC thrombectomy followed by adjuvant VAC/IE chemotherapy was evaluated on Tumour downsizing, perioperative morbidity, and 1-year disease-free status.
Synapse has enriched 10 related papers. Consider them for comparative context: